Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.

Cropley VL, Innis RB, Nathan PJ, Brown AK, Sangare JL, Lerner A, Ryu YH, Sprague KE, Pike VW, Fujita M.

Synapse. 2008 Jun;62(6):399-408. doi: 10.1002/syn.20506.

PMID:
18361438
2.

Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.

Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R.

Neuropsychopharmacology. 2006 May;31(5):1016-26.

3.

Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.

Riccardi P, Baldwin R, Salomon R, Anderson S, Ansari MS, Li R, Dawant B, Bauernfeind A, Schmidt D, Kessler R.

Biol Psychiatry. 2008 Jan 15;63(2):241-4. Epub 2007 Jun 27.

PMID:
17586476
4.

Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride.

Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE, Vora S, Litschge M, Kendro S, Cooper TB, Mathis CA, Laruelle M.

Synapse. 2009 Jun;63(6):447-61. doi: 10.1002/syn.20628.

PMID:
19217025
5.

Striatal and extrastriatal dopamine release measured with PET and [(18)F] fallypride.

Slifstein M, Kegeles LS, Xu X, Thompson JL, Urban N, Castrillon J, Hackett E, Bae SA, Laruelle M, Abi-Dargham A.

Synapse. 2010 May;64(5):350-62. doi: 10.1002/syn.20734.

6.
7.
8.

Optimized in vivo detection of dopamine release using 18F-fallypride PET.

Ceccarini J, Vrieze E, Koole M, Muylle T, Bormans G, Claes S, Van Laere K.

J Nucl Med. 2012 Oct;53(10):1565-72. doi: 10.2967/jnumed.111.099416. Epub 2012 Aug 29.

9.

Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.

Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B, Anderson S, Woodward N, Schmidt D, Baldwin R, Kessler R.

Am J Psychiatry. 2006 Sep;163(9):1639-41.

PMID:
16946193
10.
11.

Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.

Rominger A, Wagner E, Mille E, Böning G, Esmaeilzadeh M, Wängler B, Gildehaus FJ, Nowak S, Bruche A, Tatsch K, Bartenstein P, Cumming P.

Synapse. 2010 Apr;64(4):313-22. doi: 10.1002/syn.20730.

PMID:
19957365
12.

[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.

Rominger A, Cumming P, Xiong G, Koller G, Böning G, Wulff M, Zwergal A, Förster S, Reilhac A, Munk O, Soyka M, Wängler B, Bartenstein P, la Fougère C, Pogarell O.

Addict Biol. 2012 Mar;17(2):490-503. doi: 10.1111/j.1369-1600.2011.00355.x. Epub 2011 Oct 3.

PMID:
22023291
13.
14.

Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallypride.

Constantinescu CC, Coleman RA, Pan ML, Mukherjee J.

Synapse. 2011 Aug;65(8):778-87. doi: 10.1002/syn.20904. Epub 2011 Mar 21.

15.

High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol.

Vandehey NT, Moirano JM, Converse AK, Holden JE, Mukherjee J, Murali D, Nickles RJ, Davidson RJ, Schneider ML, Christian BT.

J Cereb Blood Flow Metab. 2010 May;30(5):994-1007. doi: 10.1038/jcbfm.2009.270. Epub 2009 Dec 30.

16.

In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.

Slifstein M, Hwang DR, Huang Y, Guo N, Sudo Y, Narendran R, Talbot P, Laruelle M.

Psychopharmacology (Berl). 2004 Sep;175(3):274-86.

PMID:
15024551
17.

AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.

Boot E, Booij J, Hasler G, Zinkstok JR, de Haan L, Linszen DH, van Amelsvoort TA.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1350-6. doi: 10.1007/s00259-008-0739-8. Epub 2008 Feb 19.

18.

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride.

Mukherjee J, Yang ZY, Brown T, Lew R, Wernick M, Ouyang X, Yasillo N, Chen CT, Mintzer R, Cooper M.

Nucl Med Biol. 1999 Jul;26(5):519-27.

PMID:
10473190
19.

Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.

Kegeles LS, Slifstein M, Frankle WG, Xu X, Hackett E, Bae SA, Gonzales R, Kim JH, Alvarez B, Gil R, Laruelle M, Abi-Dargham A.

Neuropsychopharmacology. 2008 Dec;33(13):3111-25. doi: 10.1038/npp.2008.33. Epub 2008 Apr 16.

20.

No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex.

Frankle WG, Mason NS, Rabiner EA, Ridler K, May MA, Asmonga D, Chen CM, Kendro S, Cooper TB, Mathis CA, Narendran R.

Synapse. 2010 Dec;64(12):879-85. doi: 10.1002/syn.20806.

PMID:
20506387

Supplemental Content

Support Center